← FDA Drug Approvals (Drugs@FDA)

NEOSTIGMINE METHYLSULFATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: BE PHARMS · Approved 2019-05-13

Drug application

FDA Application #

ANDA212512

Application type

Abbreviated New Drug Application (Generic)

Brand name

NEOSTIGMINE METHYLSULFATE

Generic name

NEOSTIGMINE METHYLSULFATE

Active ingredients

NEOSTIGMINE METHYLSULFATE

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

BE PHARMS

Manufacturer

BE Pharmaceuticals Inc.

First approval

2019-05-13

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown